Table 6: Complications in comparison to control group (Pneumonia PORT Validation Cohort [32]) in regard to mortality rate and the necessity to treat patients in ICU.

Study seriesControl group ( ) value

Treated on ICU0/26 (0%)124/1343 (9.20%)
Mortality study series ( )1/26 (3.8%)107/1343 (8%)
Mortality with excluded patients ( )3/48 (6.25%)107/1343 (8%)